CEO & Scientific Director,
Olimpia Baranowska
Olimpia Baranowska is a technical physicist, PhD candidate in Medicine, and architect of Europe's Zero-Conflict CDMO model. As CEO and Scientific Director of Olympia Biosciences™ Ltd. (Olympia Biosciences™), she has built a 17-year contract manufacturing organization with zero quality complaints — recognized at the International Businesswoman Awards in Rome and by Poland's National Centre for Research and Development.
Executive Summary
Architect of the Zero-Conflict CDMO model in Europe.
She co-founded International Organic Company (Olympia Biosciences™ Ltd.) in 2009 and has led the company through 17 years of uninterrupted operation with zero quality complaints — — a record virtually unmatched in the global contract manufacturing sector.
Her unique combination of technical physics, applied mathematics, and medical science enables an interdisciplinary approach to formulation design. It bridges quantum-level molecular understanding (biophysics of absorption) with practical clinical efficacy. Under her leadership, Olympia Biosciences™ pioneered the integration of proprietary AI models for toxicological prediction in supplement manufacturing — a pharma-grade verification layer that no other CDMO employs.
Every enterprise-level formulation project at Olympia Biosciences™ is personally overseen by our executive leadership. Apply for a rigorous technology audit to begin the process.
Academic Pedigree
MSc Eng. Technical Physics & Applied Mathematics
Gdansk University of Technology
Rigorous background in quantum physics and applied mathematics, providing the foundation for Olympia Biosciences™'s proprietary AI algorithms.
PhD Candidate in Medicine
Medical University of Gdansk
Ongoing doctoral research at the strict intersection of biophysics, pharmacogenetics, and clinical supplementation efficacy.
Key Innovations
Zero Conflict policy
She is the architect of Olympia Biosciences™'s Zero Conflict policy. The company operates exclusively as a contract manufacturer with no consumer brands, ensuring absolute loyalty to clients' intellectual property. This model was recognized at the International Businesswoman Awards in Rome and under the patronage of the National Centre for Research and Development.
AI Toxicological Prediction
Developed an AI model trained on hundreds of thousands of medical papers for ingredient interaction screening and cocktail effect analysis.
"The industry standard was to quietly reverse-engineer client success. We built a facility to protect it."
Cambridge Tech Transfer
Selected by the University of Cambridge and Adiuvo S.A. for exclusive industrial scale-up of precision micellar delivery systems.
Vegicoll® — Plant-Based Collagen
Co-developed the world's first plant-based collagen analog with hard hydroxyproline. Registered trademark Z.566783.
A decade of recognized excellence.
International Leader in Scientific Excellence
International Businesswoman Awards, Rome
Awarded for scientific leadership and the Zero Conflict manufacturing model.
Best in Business Award
NCBiR Patronage (National R&D Centre)
Recognition for ethical business practices and innovation in nutraceutical manufacturing.
Business Growth Award — Chemical Industry
European Business Institute
Top dynamic growth in the chemical industry sector.
5,000 Most Dynamic Companies in Poland
European Business Institute
National ranking of fastest-growing enterprises.
Business Growth Award — Chemical Industry (2021)
European Business Institute
Consecutive year of recognition for dynamic growth (1966% dynamics).
Business Growth Award — Regional
European Business Institute
Regional leader in business growth.
Effective Company — Chemical Industry
European Business Institute
Recognition for operational efficiency and multi-year financial stability.
The Research Dossier
Peer-reviewed articles, industry research, and expert contributions shaping the modern nutraceutical landscape.
Collagen — 20 Years of Scientific and Business Knowledge (Part 1): Structure, Composition and Fundamental Functions
Biotechnologia.pl
Collagen in Practice — Sources and Applications
Biotechnologia.pl
Innovations in Collagen — Modern Forms and the Future of Industry
Biotechnologia.pl
Pharmacogenetics — The Future of Personalized Medicine
Pharmaceutical Industry World
Application of Supplementation in Nervous System Protection
Pharmaceutical Industry World
Hyperbaric Oxygen Therapy in Rehabilitation
Practical Physiotherapy
Collagen Hydrolysates — Comparative Market Analysis
Cosmetic Industry World
Not All Collagen Is Equal — Market Comparison
Cosmetic Industry World
Featured In Media
Algorithm in a Capsule
Feature on Olympia Biosciences™'s proprietary AI model for toxicological prediction in supplement manufacturing.
Collagen Vege Presentation
Presentation of the world's first plant-based collagen analog, co-developed by Olimpia Baranowska.
zero quality complaints
— a record virtually unmatched in the global contract manufacturing sector.
“The industry standard was to quietly reverse-engineer client success. We built a facility to protect it.”
Olimpia Baranowska
CEO & Scientific Director,
Verification
Olimpia Baranowska: MSc Eng. Technical Physics & Applied Mathematics — Gdansk University of Technology. PhD Candidate in Medicine — Medical University of Gdansk.
Work directly with our scientific team.
Every enterprise-level formulation project at Olympia Biosciences™ is personally overseen by our executive leadership. Apply for a rigorous technology audit to begin the process.